CFO of Auxilium Pharmaceuticals Inc. (AUXL) James E Fickenscher sells 4,000 shares of AUXL on 09/08/2009 at an average price of $30 a share.

Auxilium Pharmaceuticals Inc. is a specialty pharmaceutical company that develops and markets products for urology and sexual health. Auxilium markets Testim 1% a topical testosterone gel for the treatment of hypogonadism. Auxilium is developing additional Testim line extensions as well as other products for urology and sexual health including an enzyme in Phase II for the treatment of Peyronie's Disease that may also prove useful for the treatment of Dupuytren's Disease. Auxilium Pharmaceuticals Inc. has a market cap of $1.33 billion; its shares were traded at around $31.11 with and P/S ratio of 10.6.

Recent Trades of Auxilium Pharmaceuticals Inc. by CEO:

• Sell: CEO & President Armando Anido sold 30,000 shares of AUXL stock on 06/26/2009 at the average price of $30.3; the price of the stock has increased by 2.67% since.


• Sell: CEO & President Armando Anido sold 30,000 more shares of AUXL stock on 03/16/2009 at the average price of $29.73; the price of the stock has increased by 4.64% since.

Recent Trades of Auxilium Pharmaceuticals Inc. by CFO:

• Sell: CFO James E Fickenscher sold 4,000 shares of AUXL stock on 07/15/2009 at the average price of $30.01; the price of the stock has increased by 3.67% since.


• Sell: CFO James E Fickenscher sold 4,000 more shares of AUXL stock on 06/15/2009 at the average price of $27.21; the price of the stock has increased by 14.33% since.


• Sell: CFO James E Fickenscher sold 4,000 more shares of AUXL stock on 05/22/2009 at the average price of $25.02; the price of the stock has increased by 24.34% since.


• Sell: CFO James E Fickenscher sold 4,000 more shares of AUXL stock on 04/17/2009 at the average price of $25.01; the price of the stock has increased by 24.39% since.


• Sell: CFO James E Fickenscher sold 4,933 more shares of AUXL stock on 03/16/2009 at the average price of $29.79; the price of the stock has increased by 4.43% since.

Recent Trades of Auxilium Pharmaceuticals Inc. by Directors and Officers:

• Sell: Executive VP & General Counsel Jennifer Evans Stacey sold 6,333 shares of AUXL stock on 07/24/2009 at the average price of $32.13; the price of the stock has decreased by 3.17% since.


• Sell: Executive VP, Sales & Mktg Roger D Jr Graham sold 550 shares of AUXL stock on 07/24/2009 at the average price of $32; the price of the stock has decreased by 2.78% since.

Why CEOs Are Buying Stocks Of Their Own Companies?

1. As legendary investor Peter Lynch said: "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise."
2. TOP EXECUTIVES like CEOs and CFOs are savvy buyers of their companies' shares. One long-term study showed that they beat the market on average by six percentage points a year.
3. Another study found that the aggregated activities of insiders can serve as a good indicator to locate market bottoms. Insiders as a whole are smart investors of their own companies.

Click it to Check Out What the CEO Are Trading

More Gurufocus Links

Latest Guru Picks	Value Strategies
Warren Buffett Portfolio	Ben Graham Net-Net
Real Time Picks	Buffett-Munger Screener
Aggregated Portfolio	Undervalued Predictable
ETFs, Options	Low P/S Companies
Insider Trends	10-Year Financials
52-Week Lows	Interactive Charts
Model Portfolios	DCF Calculator
RSS Feed	Monthly Newsletters
The All-In-One Screener	Portfolio Tracking Tool